Lithuania’s Biomatter raises $18M for AI enzyme design
Vilnius-based Biomatter has raised $18M in a Series A round to scale its AI enzyme design platform. Astanor led the oversubscribed round. Existing investors UVC Partners, Inventure and Metaplanet also took part.
Read the full story on The Next Web.